4//SEC Filing
SCANGOS GEORGE A 4
Accession 0001628280-24-043632
CIK 0001706431other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:26 PM ET
Size
11.6 KB
Accession
0001628280-24-043632
Insider Transaction Report
Form 4
SCANGOS GEORGE A
Director
Transactions
- Other
Common Stock
2024-10-23−598,270→ 1,151,730 total(indirect: See footnote) - Other
Common Stock
2024-10-23−598,270→ 1,151,730 total(indirect: See footnote) - Other
Common Stock
2024-10-23+598,270→ 719,259 total - Other
Common Stock
2024-10-23+598,270→ 598,270 total(indirect: See footnote)
Holdings
- 33,629(indirect: See footnote)
Common Stock
- 179,930(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Transfer without consideration for tax planning purposes.
- [F2]The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F3]The shares are held by the spouse of the reporting person.
- [F4]The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F5]The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
- [F6]The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001202102
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 4:26 PM ET
- Size
- 11.6 KB